Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 16/9/2019
SIETES contiene 92806 citas

 
 
 1 a 20 de 514 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Imperiale TF, Gruber RN, Stump TE, Emmett TW, Monahan PO. Performance characteristics of fecal immunochemical tests for colorectal cancer and advanced adenomatous polyps: a systematic review and meta-analysis. Ann Intern Med 2019:26 de febrero. [Ref.ID 103034]
2.Enlace a cita original Cita con resumen
Valles-Colomer M, Falongy G, Darzi Y, Tigchelaar EF, Wang J, Tito RY, Schiweck C, Kurilshikov A, Joossens M, Wijmenga C, Claes S, Van Oudenhove L, Zhernakova A, Vieira-Silva S, Raes J. The neuroactive potential of the human gut microbiota in quality of life and depression. Nat Microbiol 2019:4 de febrero. [Ref.ID 103027]
3.Enlace a cita original Cita con resumen
Hadland SE, Rivera-Aguirre A, Marshall BDL, Cerdá M. Association of pharmaceutical industry marketing of opioid products with mortality from opioid-related overdoses. JAMA Network Open 2019;2:18 de enero. [Ref.ID 103009]
4.Enlace a cita original Cita con resumen
Vedal TSJ, Steen NE, Birkeland KI, Dieset I, Reponen EJ, Laskemoen JF, Rodevand L, Melle I, Andreassen OA, Molden E, Jönsson EG. Free thyroxine and thyroid-stimulating hormone in severe mental disorders: A naturalistic study with focus on antipsychotic medication. J Psychiatr Res 2018:25 de septiembre. [Ref.ID 102832]
5. Cita con resumen
Wen H, Hockenberry JM. Association of medical and adult-use marijuana laws with opioid prescribing for Medicaid enrollees. JAMA Intern Med 2018;178:mayo. [Ref.ID 102740]
6.Enlace a cita original Cita con resumen
O'Connell J, Burke E, O'Dwyer C, Donegan C, McCallion P, McCarron M, Henman MC, O'Dwyer M. Drug burden index to define the burden of medicines in older adults with intellectual disabilities: An observational cross-sectional study. Br J Clin Pharmacol 2018;84:marzo. [Ref.ID 102650]
7.Tiene citas relacionadas Cita con resumen
Öngür D. Dopamine dysfunction in schizophrenia and bipolar disorder - Never the twain shall meet?. JAMA Psychiatry 2017:11 de octubre. [Ref.ID 102090]
8.Tiene citas relacionadas Cita con resumen
Jauhar S, Nour MM, Veronese M, Rogdaki M, Bonoldi I, Azis M, Turkheimer F, McGuire P, Young AH, Howes OD. A tests of the transdiagnostic dopamine hypothesis of psychosis using positron emission tomographic imaging in bipolar affective disorder and schizophrenia. JAMA Psychiatry 2017:11 de octubre. [Ref.ID 102089]
9. Cita con resumen
Xu J, Emenanjo O, Ortwerth M, Lurie P. Association of appearance of conflicts of interest with voting behavior at FDA advisory committee meetings—A cross-sectional study. JAMA Intern Med 2017;177:1038-40. [Ref.ID 101664]
10. Cita con resumen
Huizinga P, Kluytmans-van den Bergh M, van Rijen M, Willemsen I, van't Veer N, Kluytmans J. Proton pump inhibitor use is associated with extended-spectrum ß-lactamase-producing enterobacteriaceae rectal carriage at hospital admission: a cross-sectional study. Clin Infect Dis 2017;64:361-3. [Ref.ID 101508]
11. Cita con resumen
Anónimo. Understanding observational studies. Drug Ther Bull 2016;54:105-8. [Ref.ID 100726]
12. Cita con resumen
Johansen ME, Richardson C. Estimation of potential savings through therapeutic substitution. JAMA Intern Med 2016;176:769-75. [Ref.ID 100398]
13. Cita con resumen
Salat D, Llop R, Aguilera C, Danés I, Bosch M, Asensio C, Castañeda F, Esterlich E, Vallano A. Therapeutics enquiries about biological agents as a tool to identify safety aspects and patterns of use. European Journal of Hospital Pharmacy 2016;23:161-5. [Ref.ID 100163]
14. Cita con resumen
Herr M, Robine J-M, Pinot J, Arvieu J-J, Ankri J. Polypharmacy and frailty: prevalence, relationship, and impact on mortality in a French sample of 2350 old people. Pharmacoepidemiol Drug Saf 2015;24:637-46. [Ref.ID 99854]
15.Tiene citas relacionadas Cita con resumen
Cheungpasitporn W, Thongprayoon C, Kittanamongkolchai W, Srivali N, Edmonds PJ, Ungprasert P, O'Corragain OA, Korpaisarn S, Erickson SB. Proton pump inhibitors linked to hypomagnesemia: a systematic review and meta-analysis of observational studies. Renal Failure 2015;37:1237-41. [Ref.ID 99742]
16. Cita con resumen
Cheungpasitporn W, Thongprayoon C, Mao MA, Srivali N, Ungprasert P, Varothai N, Sanguankeo A, Kittanamongkolchai W, Erickson SB. Hypomagnesaemia linked to depression: a systematic review and meta-analysis. Internal Medicine Journal 2015;45:436-40. [Ref.ID 99741]
17.Tiene citas relacionadas Cita con resumen
Hayakawa T, McGarrigle CA, Coen RF, Soraghan CJ, Foran T, Lawlor BA, Kenny RA. Orthostatic blood pressure behavior in people with mild cognitive impairment predicts conversion to dementia. J Am Geriatr Soc 2015;63:1868-73. [Ref.ID 99562]
18.Tiene citas relacionadas Cita con resumen
Ogliari G, Sabayan B, Mari D, Rossi PD, Lucchi TA, de Craen AJ, Westendorp RG. Age- and functional status-dependent association between blood pressure and cognition: the Milan Geriatrics 75+ Cohort Study. J Am Geriatr Soc 2015;63:1741-8. [Ref.ID 99561]
19.Tiene citas relacionadas Cita con resumen
Brett AS. Low blood pressure and cognitive impairment in elders. Journal Watch 2015:6 de octubre. [Ref.ID 99560]
20. Cita con resumen
Martín-González A, Abajo del Álamo C, Catalá Pindado MA, Godoy Díez M. Calidad de la prescripción para indicaciones no autorizadas en ficha técnica (off-label) en la enfermedad oncológica avanzada. Med Clin (Barc) 2015;145:178-9. [Ref.ID 99477]
Seleccionar todas
 
 1 a 20 de 514 siguiente >>